Refractory Classic Hodgkin Lymphoma

Also known as: Classical Hodgkin lymphoma refractory / Refractory Classical Hodgkin's Lymphoma / Refractory Classical Hodgkin Lymphoma / Refractory Hodgkin lymphoma (disorder) / Hodgkin's disease NOS refractory / Hodgkin's disease refractory

DrugDrug NameDrug Description
DB09037PembrolizumabA PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma.
DrugDrug NamePhaseStatusCount
DB00928Azacitidine1Recruiting1
DB06186Ipilimumab1Recruiting1
DB09035Nivolumab1Recruiting2
DB09037Pembrolizumab1Active Not Recruiting2
DB02546Vorinostat1Active Not Recruiting1
DB17404AFM-131 / 2Active Not Recruiting1
DB18674Acimtamig1 / 2Active Not Recruiting1
DB08870Brentuximab vedotin1 / 2Suspended1
DB00531Cyclophosphamide1 / 2Active Not Recruiting1
DB01073Fludarabine1 / 2Active Not Recruiting1
DB06186Ipilimumab1 / 2Suspended1
DB09035Nivolumab1 / 2Suspended1
DB00928Azacitidine2Recruiting1
DB02379Beta-D-Glucose2Completed1
DB00188Bortezomib2Completed1
DB16741Bortezomib D-mannitol2Completed1
DB08870Brentuximab vedotin2Recruiting1
DB00958Carboplatin2Completed1
DB00531Cyclophosphamide2Completed1
DB00773Etoposide2Completed1
DB01181Ifosfamide2Completed1
DB16225Magrolimab2Recruiting1
DB09035Nivolumab2Recruiting1
DB09037Pembrolizumab2Recruiting1
DB06769Bendamustine3Withdrawn1
DB02379Beta-D-Glucose3Withdrawn1
DB08870Brentuximab vedotin3Withdrawn1
DB00958Carboplatin3Withdrawn1
DB00531Cyclophosphamide3Withdrawn1
DB00997Doxorubicin3Withdrawn1
DB00773Etoposide3Withdrawn1
DB00441Gemcitabine3Withdrawn1
DB01181Ifosfamide3Withdrawn1
DB09037Pembrolizumab3Withdrawn1
DB00759Tetracycline3Withdrawn1
DB00361Vinorelbine3Withdrawn1
DB17505Zimberelimab3Not Yet Recruiting1